We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

1530:HKEXAwea mechantronic co.,ltd Analysis

Data as of 2026-06-11 - not real-time

NT$30.35

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Awea mechantronic is trading at TWD 30.35, just shy of its 20‑day SMA (30.99) but comfortably above the 50‑day (28.44) and 200‑day (27.81) averages, indicating a bullish medium‑term trend. The RSI sits at 49, suggesting neither overbought nor oversold conditions, while the MACD histogram is negative and the signal line is bearish, pointing to short‑term momentum weakness. Volume has been decreasing, and the current volume (255,255) is well below the 10‑day average (586,885), raising concerns about liquidity. The stock’s beta of 0.15 and a 30‑day volatility of nearly 49% imply low market correlation but high price swings, a risky mix for risk‑averse investors. Fundamentally, the trailing PE of 50.6 far exceeds the industry average of 29.5, yet the forward PE collapses to 18.1, reflecting expectations of earnings improvement. Profit margins are thin (6% net) and operating margins are negative, with free cash flow in the red and a debt‑to‑equity ratio of 51%, highlighting financial strain. The dividend yield is attractive at 4.85%, but a payout ratio of over 250% is unsustainable, casting doubt on future payouts.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 5/10

Key Factors

  • Price slightly below 20‑day SMA
  • Bearish MACD signal
  • Decreasing trading volume

Medium Term

1–3 years
Neutral
Model confidence: 6/10

Key Factors

  • Forward PE of 18 suggests earnings upside
  • Strong dividend yield but unsustainable payout
  • Bullish trend above 50‑day and 200‑day SMAs

Long Term

> 3 years
Cautious
Model confidence: 7/10

Key Factors

  • Trailing PE more than double industry average
  • Negative operating cash flow and high debt ratio
  • Low profitability margins and volatile price swings

Key Metrics & Analysis

Financial Health

Revenue Growth-19.50%
Profit Margin6.00%
P/E Ratio50.6
ROE3.19%
ROA-0.61%
Debt/Equity51.22
P/B Ratio0.9
Op. Cash FlowNT$58.0M
Free Cash FlowNT$-37232624
Industry P/E29.5

Technical Analysis

TrendBullish
RSI49.4
SupportNT$26.25
ResistanceNT$36.80
MA 20NT$30.99
MA 50NT$28.44
MA 200NT$27.81
MACDBearish
VolumeDecreasing
Fear & Greed Index83.61

Valuation

Fair ValueNT$1.54
GradeOvervalued
TypeValue
Dividend Yield4.85%

Risk Assessment

Beta0.15
Volatility48.87%
Sector RiskMedium
Reg. RiskLow
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.